Clinical trial developed at Massey tests novel combination of chemotherapy and radiation therapy for the treatment of pancreatic cancer
A phase 1 clinical trial developed at VCU Massey Cancer Center is testing a combination of targeted therapy with standard chemotherapy and radiation given prior to surgery in patients with non-metastatic pancreatic cancer. Surgery is often the most effective treatment for pancreatic cancer, but in many cases it is not possible if the tumor has spread to other parts of the digestive system or nearby organs. Neoadjuvant therapy, or therapy prior to surgery, can help shrink tumors and make them operable.
In pre-clinical experiments, researchers at VCU Massey Cancer Center have reported promising results toward the eradication of breast cancer recurrence through a combination of chemotherapy and immunotherapy. Breast cancer is the most frequently diagnosed non-skin cancer in women and ranks second among cancer deaths in women after lung cancer. An estimated 246,660 new cases of invasive breast cancer will be diagnosed in women in the U.S. in 2016, and approximately 2,600 new cases in men, according to Breastcancer.org.
Governor Terry McAuliffe recently announced the appointment of Heather A. Creswick, M.S., C.G.C., and John M. Quillin, Ph.D., C.G.C., both genetic counselors at VCU Massey Cancer Center’s Familial Cancer Clinic, to Virginia’s Advisory Board on Genetic Counseling (AB).
According to the American Cancer Society, there are more than 14 million cancer survivors in the United States, and there are expected to be 18 million by 2022—that is 18 million people who have had their lives up-ended by cancer, faced their mortality, suffered through treatment and redefined their definition of a “normal” life. And when you think of how these effects ripple through the lives of their caregivers and loved ones, the number of people affected by cancer grows tremendously.
VCU Massey Cancer Center physician-researcher Todd Adams, M.D., was recently awarded the 2016 Sherry Kohlenberg Healthcare Service Award from the Virginia Breast Cancer Foundation (VBCF) for his “commitment to the fight against breast cancer”.
Adams is a radiation oncologist and member of the Developmental Therapeutics research program at Massey as well as an assistant professor in the Department of Radiation Oncology at VCU School of Medicine.
The award was named after a former healthcare administrator and co-founder of the VBCF who died from breast cancer in 1993. The award is given by the VBCF to recognize health care workers in Virginia who “exhibit a deep and abiding commitment to the fight against breast cancer.”